60 Degrees Pharmaceuticals, Inc. (SXTP)
USD 1.38
(-6.76%)
USD 1.38
(-6.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -4.54 Million | -1 Million | -649.1 Thousand | -167.29 Thousand |
| Net Income | -3.7 Million | -6.17 Million | -4.26 Million | -3.04 Million |
| Depreciation & Amortization | 100.37 Thousand | 78.78 Thousand | 71.78 Thousand | 27.86 Thousand |
| Deferred income taxes | -1.91 Million | - | - | - |
| Stock-based compensation | 1.52 Million | - | - | - |
| Change in working capital | 405.36 Thousand | 3.3 Million | 2.89 Million | 2.42 Million |
| Other non-cash items | -956.69 Thousand | 1.78 Million | 642.91 Thousand | 425.74 Thousand |
| Investing Cash Flow | -115.88 Thousand | -60.13 Thousand | -35.39 Thousand | -70.97 Thousand |
| Investments in PPE | -115.88 Thousand | -60.13 Thousand | -35.39 Thousand | -70.97 Thousand |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -58.26 Thousand | -60.13 Thousand | -32.32 Thousand | -70.97 Thousand |
| Financing Cash Flow | 6.47 Million | 1.22 Million | 611.22 Thousand | 277.35 Thousand |
| Debt repayment | -961.11 Thousand | -1.29 Million | -72 Thousand | -151.14 Thousand |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 7.58 Million | - | - | - |
| Other Financing Activities | -150.42 Thousand | 2.51 Million | 683.22 Thousand | 428.5 Thousand |
| Accounts receivables | -185.36 Thousand | 100.39 Thousand | 713.06 Thousand | -660.27 Thousand |
| Accounts payables | -214.73 Thousand | 169.99 Thousand | -844.67 Thousand | 796.29 Thousand |
| Inventory | 212.74 Thousand | -52.93 Thousand | 312.22 Thousand | 190.77 Thousand |
| Other working capital | 592.71 Thousand | 3.08 Million | 2.71 Million | 2.1 Million |
| Cash at beginning of period | 264.86 Thousand | 115.39 Thousand | 191.7 Thousand | 286.87 Thousand |
| Cash at end of period | 2.14 Million | 264.86 Thousand | 115.39 Thousand | 191.7 Thousand |
| Capital Expenditure | -115.88 Thousand | -60.13 Thousand | -35.39 Thousand | -70.97 Thousand |
| Effect of forex changes on cash | 61.85 Thousand | -2127.00 | -3031.00 | -134.25 Thousand |
| Net cash flow / Change in cash | 1.87 Million | 149.46 Thousand | -76.3 Thousand | -95.17 Thousand |
| Free Cash Flow | -4.65 Million | -1.07 Million | -684.49 Thousand | -238.27 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.16 Million | 430.47 Thousand | -3.7 Million | -1.95 Million | 4.17 Million | -3.34 Million |
| Depreciation & Amortization | 11 Thousand | 22.13 Thousand | 100.37 Thousand | 23.44 Thousand | 25.43 Thousand | 24.99 Thousand |
| Deferred income taxes | - | - | -1.91 Million | -565.76 Thousand | -5.84 Million | 1.71 Million |
| Stock-based compensation | -125.36 Thousand | 125.36 Thousand | 1.52 Million | 852.69 Thousand | 393.26 Thousand | -255.82 Thousand |
| Change in working capital | 221.23 Thousand | 16.54 Thousand | 405.36 Thousand | 1.3 Million | -2.53 Million | 887.51 Thousand |
| Other non-cash items | 2.64 Million | -1.53 Million | -956.69 Thousand | 275.52 Thousand | 27.3 Thousand | 334.3 Thousand |
| Investing Cash Flow | -130.55 Thousand | -9814.00 | -115.88 Thousand | -66.56 Thousand | -27.9 Thousand | -18.12 Thousand |
| Investments in PPE | -130.55 Thousand | -9814.00 | -115.88 Thousand | -66.56 Thousand | -27.9 Thousand | -18.12 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -130.55 Thousand | -9814.00 | -58.26 Thousand | -10.76 Thousand | -26.08 Thousand | -18.12 Thousand |
| Financing Cash Flow | -865.00 | 1.9 Million | 6.47 Million | -1.00 | 5.97 Million | 321.06 Thousand |
| Debt repayment | - | - | -961.11 Thousand | -2.26 Million | -1.61 Million | -650 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -17.08 Thousand | 1.91 Million | 7.58 Million | -150.42 Thousand | 6.45 Million | 7.21 Million |
| Other Financing Activities | 16.21 Thousand | -16.21 Thousand | -150.42 Thousand | 150.42 Thousand | 1.12 Million | 971.06 Thousand |
| Accounts receivables | 19.85 Thousand | -84.88 Thousand | -185.36 Thousand | -93.32 Thousand | -12.53 Thousand | -42.61 Thousand |
| Accounts payables | 100.15 Thousand | 23.24 Thousand | -214.73 Thousand | 274.6 Thousand | -788.99 Thousand | 222.61 Thousand |
| Inventory | 9357.00 | 30.79 Thousand | 212.74 Thousand | 152.54 Thousand | 59.44 Thousand | 108.84 Thousand |
| Other working capital | 91.87 Thousand | 47.4 Thousand | 592.71 Thousand | 974.71 Thousand | -1.78 Million | 598.67 Thousand |
| Cash at beginning of period | 2.89 Million | 2.14 Million | 264.86 Thousand | 2.21 Million | 19.07 Thousand | 29.99 Thousand |
| Cash at end of period | 1.57 Million | 2.89 Million | 2.14 Million | 2.14 Million | 2.19 Million | 19.07 Thousand |
| Capital Expenditure | -130.55 Thousand | -9814.00 | -115.88 Thousand | -66.56 Thousand | -27.9 Thousand | -18.12 Thousand |
| Effect of forex changes on cash | 1538.00 | -824.00 | 61.85 Thousand | 54.17 Thousand | 9342.00 | -374.00 |
| Net cash flow / Change in cash | -1.31 Million | 752.21 Thousand | 1.87 Million | -76.05 Thousand | 2.18 Million | -10.92 Thousand |
| Free Cash Flow | -1.31 Million | -1.15 Million | -4.65 Million | -130.22 Thousand | -3.78 Million | -331.61 Thousand |
REDINGTON
1619
1795
VGUARD
3209
4160